HEALTHSTREAM INC 8-K

What Happened

• HealthStream, Inc. filed an 8-K on May 8, 2026, disclosing that Michael M. Collier was promoted (announced in a May 4, 2026 press release) from EVP, Corporate Strategy, Development & Operations to Chief Operating Officer and Executive Vice President. Collier will lead enterprise operations (customer experience, corporate development and M&A, implementations, legal, HR, partnerships, business enablement, etc.) and serve as executive sponsor of the company’s AI transformation.
• In connection with the promotion, the Compensation Committee approved a letter agreement that increases Collier’s base salary, makes him eligible for the company’s executive-level annual cash bonus and annual time‑based RSU awards, and grants him stock options. Separately, the Committee granted the CEO, Robert A. Frist, Jr., a matching stock option award.

Key Details

• Option grants: 18,781 stock options each to Michael M. Collier and to CEO Robert A. Frist, Jr.; grant date May 8, 2026; exercise price $23.96 per share (closing price on grant date).
• Vesting schedule (both grants): 15% at 1 year, 20% at 2 years, 20% at 3 years, 20% at 4 years, 25% at 5 years — vesting is time‑based and subject to continued service.
• Combined potential shares from these two grants: 37,562 shares; if exercised at $23.96 per share, gross proceeds to the company would be roughly $900,000 (37,562 × $23.96).
• Filing notes no family relationships or related-party transactions requiring disclosure; a fuller biography of Collier is available in the company’s 2025 Form 10-K filed Feb 26, 2026.

Why It Matters

• The promotion signals an operational leadership change and assigns Collier responsibility for execution across key operational and transformation initiatives, including AI — potentially important for investors watching operational efficiency and strategic direction.
• The time‑based option grants align Collier’s and the CEO’s compensation with multi‑year retention and performance incentives; the vesting schedule and exercise price mean any dilution is spread over several years and recognition of related compensation expense will be gradual.
• The grants are modest in size relative to typical public-company share counts; still, investors should note potential future dilution and the company’s continued emphasis on tying executive pay to long‑term service and strategic priorities.